ROKIT America, Inc. (RKAM)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	262.50M
Revenue (ttm)	7.43M +139.9%
Net Income	1.59M +143.5%
EPS	0.06
Shares Out	27.63M
PE Ratio	165.46
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About RKAM

ROKIT America is committed to extending human healthspan and enhancing quality of life in an aging society through its proprietary Reverse Aging Product which is intended to support cellular health and aging-related biological processes at the molecular level, and its artificial intelligence hyper-personalized Organ Regeneration Platform, a proprietary technology developed by our parent company, ROKIT Healthcare, which is intended to provide regenerative medicine solutions in the Americas. Since its founding in 2019, the Company has focused on ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2019
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: RKAM
• Website: https://rokitamerica.co.kr/

Financial Performance

Data Source: SEC filings Last updated: Aug 20, 2026

The data for this page was gathered manually by the Stock Analysis team, from official company filings available on SEC.gov.

Data Sources Report a data error